Literature DB >> 2921131

Long-term observation after radiotherapy for nasopharyngeal carcinoma (NPC).

W Z Chen1, D L Zhou, K S Luo.   

Abstract

One thousand one hundred twenty-seven cases of nasopharyngeal carcinoma were treated with routine radiotherapy from October 1969 to March 1976, of which 436 cases have survived for more than 5 years, 323 cases have survived for over 10 years. The follow-up rate was 98.4%. The present paper analyzes the factors involved in these 436 cases. All patients were treated with tele60Co unit, and in the neck some cases were treated with orthovoltage therapy. The total dose to the primary lesion was 60-75 Gy in 6-8 weeks and in a few cases over 80 Gy were needed, and 50 Gy were applied bilateral cervical lymphatic chain. In this series of cases the 10-year overall survival rate was 28.7%, with Stage I being 66.7%, Stage II 46.5%, Stage III 28.0%, and Stage IV 18.6%, respectively. Statistically, 68 cases died of cardiovascular and other diseases and should be eliminated for net survival calculations. Therefore, we could obtain an actual 10-year survival rate of 30.5%. However, it should be noted that most of these cases were advanced, with Stage III, IV accounting for 82.3%, thus at Stage I, II the 10-year survival rate was 48%, while at Stage III, IV rate was down to 24.5%, which was statistically significant (p less than 0.01). Local and cervical recurrence as well as distant spread of diseases, for these cases started from the fifth to the tenth year after radiotherapy, the mortality caused by the above-mentioned three sites together was 76.9%. According to these findings, we propose that follow-up after radiotherapy in NPC exceeds 10-years. Of the 323 NPC cases, 10 were nasopharyngeal local recurrence which were re-irradiated, accounting for 3.1%. This paper shows that the 3-year survival rate in the local recurrence which were re-irradiated was 34.5%, the 5-year survival rate was 14.8%, and the 10-year survival rate was 11.5%. The failure after re-irradiation was caused by local recurrence and metastasis with a mortality of 83.6%. These results emphasize that the success of initial irradiation is important.

Entities:  

Mesh:

Year:  1989        PMID: 2921131

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: Evolving technical choices and survival.

Authors:  S Tonoli; S M Magrini; L Costa; F Paiar; G Simontacchi; V Scotti; N Pasinetti; R Barca; D Barbieri; A De Stefani; E Cellai; M Buglione; G Biti
Journal:  Radiol Med       Date:  2011-11-17       Impact factor: 3.469

2.  Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes?

Authors:  Tzu-Chen Yen; Yu-Chen Chang; Sheng-Chieh Chan; Joseph Tung-Chieh Chang; Ching-Han Hsu; Kun-Ju Lin; Wuu-Jyh Lin; Ying-Kai Fu; Shu-Hang Ng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-30       Impact factor: 9.236

3.  Outcome of surgical management of persistent or recurrent neck mass in patients with nasopharyngeal carcinoma after radiotherapy.

Authors:  Cheng-Yu Lin; Sen-Tien Tsai; Ying-Tai Jin; Ming-Wei Yang; I-Chun Yeh; Jenn-Ren Hsiao
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-12-07       Impact factor: 2.503

4.  Dysphagia in patients with nasopharyngeal cancer after radiation therapy: a videofluoroscopic swallowing study.

Authors:  Yeun-Chung Chang; Ssu-Yuan Chen; Louis Tak Lui; Tyng-Guey Wang; Teh-Chen Wang; Tzu-Yu Hsiao; Yiu-Wah Li; I-Nan Lien
Journal:  Dysphagia       Date:  2003       Impact factor: 3.438

5.  Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma.

Authors:  Lei Ma; Gong Zhang; Xiao-Bo Miao; Xu-Bin Deng; Yue Wu; Ying Liu; Zhi-Ru Jin; Xi-Qing Li; Qiu-Zhen Liu; Du-Xin Sun; Joseph R Testa; Kai-Tai Yao; Guang-Hui Xiao
Journal:  FEBS J       Date:  2013-04-08       Impact factor: 5.542

6.  Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5-fluorouracil in locally advanced nasopharyngeal carcinoma.

Authors:  Tanadech Dechaphunkul; Kowit Pruegsanusak; Duangjai Sangthawan; Patrapim Sunpaweravong
Journal:  Head Neck Oncol       Date:  2011-06-05

7.  Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.

Authors:  M Benasso; G Sanguineti; M D'Amico; R Corvò; I Ricci; G Numico; D Guarneri; V Vitale; E Pallestrini; A Santelli; R Rosso
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

Review 8.  Role of chemotherapy in nasopharyngeal carcinoma.

Authors:  Fabiola Paiar; Vanessa Di Cataldo; Giacomo Zei; Eleonora Monteleone Pasquetti; Sara Cecchini; Icro Meattini; Monica Mangoni; Benedetta Agresti; Carmine Iermano; Pierluigi Bonomo; Giampaolo Biti
Journal:  Oncol Rev       Date:  2012-01-05

9.  CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway.

Authors:  Jing Yang; Xing Lv; Jinna Chen; Changqing Xie; Weixiong Xia; Chen Jiang; Tingting Zeng; Yanfang Ye; Liangru Ke; Yahui Yu; Hu Liang; Xin-Yuan Guan; Xiang Guo; Yanqun Xiang
Journal:  Oncotarget       Date:  2016-03-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.